https://www.selleckchem.com/pr....oducts/nmda-n-methyl
Besides motor symptoms, many individuals with Parkinson's disease develop cognitive impairment perhaps due to co-existing α-synuclein and Alzheimer's disease pathologies and impaired brain insulin signaling. Discovering biomarkers for cognitive impairment in Parkinson's disease could help clarify the underlying pathogenic processes and improve Parkinson's disease diagnosis and prognosis. This study used plasma samples from 271 participants 103 Parkinson's disease individuals with normal cognition, 121 Parkinson's d
Like
Comment
Share
